La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Eyebright Medical Technology (Beijing) Résultats passés
Passé contrôle des critères 2/6
Eyebright Medical Technology (Beijing) has been growing earnings at an average annual rate of 35.6%, while the Medical Equipment industry saw earnings growing at 5.8% annually. Revenues have been growing at an average rate of 36.8% per year. Eyebright Medical Technology (Beijing)'s return on equity is 12.6%, and it has net margins of 30.6%.
Informations clés
35.6%
Taux de croissance des bénéfices
31.1%
Taux de croissance du BPA
| Medical Equipment Croissance de l'industrie | 16.0% |
| Taux de croissance des recettes | 36.8% |
| Rendement des fonds propres | 12.6% |
| Marge nette | 30.6% |
| Prochaine mise à jour des résultats | 22 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15
Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Ventilation des recettes et des dépenses
Comment Eyebright Medical Technology (Beijing) gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Mar 24 | 1,072 | 328 | 345 | 93 |
| 31 Dec 23 | 951 | 304 | 309 | 92 |
| 30 Sep 23 | 806 | 287 | 276 | 85 |
| 30 Jun 23 | 713 | 272 | 239 | 79 |
| 31 Mar 23 | 638 | 252 | 205 | 72 |
| 31 Dec 22 | 579 | 233 | 187 | 64 |
| 30 Sep 22 | 549 | 229 | 168 | 59 |
| 30 Jun 22 | 500 | 203 | 160 | 56 |
| 31 Mar 22 | 480 | 194 | 157 | 54 |
| 31 Dec 21 | 433 | 171 | 148 | 52 |
| 30 Sep 21 | 416 | 168 | 137 | 48 |
| 30 Jun 21 | 376 | 150 | 122 | 40 |
| 31 Mar 21 | 331 | 129 | 107 | 36 |
| 31 Dec 20 | 273 | 97 | 98 | 30 |
| 30 Sep 20 | 237 | 86 | 86 | 26 |
| 30 Jun 20 | 204 | 68 | 82 | 24 |
| 31 Mar 20 | 178 | 53 | 84 | 23 |
| 31 Dec 19 | 195 | 67 | 82 | 22 |
| 31 Dec 18 | 127 | 20 | 71 | 14 |
| 31 Dec 17 | 75 | -4 | 55 | 7 |
Des revenus de qualité: 688050 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 688050's current net profit margins (30.6%) are lower than last year (39.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 688050's earnings have grown significantly by 35.6% per year over the past 5 years.
Accélération de la croissance: 688050's earnings growth over the past year (30.1%) is below its 5-year average (35.6% per year).
Bénéfices par rapport au secteur d'activité: 688050 earnings growth over the past year (30.1%) exceeded the Medical Equipment industry 1.7%.
Rendement des fonds propres
ROE élevé: 688050's Return on Equity (12.6%) is considered low.